Pharmaceuticals The most-up-to-date pharmaceutical news stories, including medical, cosmetic, and supplemental treatments. This section contains releases covering all aspects of the pharmaceutical sector, from research, development, and testing, through to product launches and marketing. Topics include clinical trials and studies, as well as updates on the FDA approval process for new treatment options. Learn about upcoming events, conferences, and educational initiatives. Also included is financial and corporate information from the sector, such as board decisions, appointments and changes, industry awards, and quarterly reports.

Latest

25 May, 2017, 14:12 ET The Parenteral Drug Association Connecting Drug Manufacturers, Glass Suppliers to make Manufacturing Great

The Parenteral Drug Association (PDA) is proud to announce a significant initiative to bring together executives, including CEOs and executive vice...


25 May, 2017, 14:10 ET Great Place to Work® and Fortune Name Astellas to Inaugural Best Workplaces in Chicago List

Today, Great Place to Work® and Fortune magazine announced their inaugural 50 Best Workplaces in Chicago list. Astellas ranked among the Top 20...


25 May, 2017, 10:53 ET DrFirst Presents An Intelligent Medication Management Showcase At MEDITECH's 2017 International MUSE Conference

DrFirst, the market leader in delivering intelligent medication management solutions that improve patient safety, announced its sponsorship of...


25 May, 2017, 10:31 ET PharmaMar and Eczacıbaşı Sign a Licensing Agreement for Aplidin® in Turkey

PharmaMar (MCE:PHM) has announced today a licensing agreement with Eczacıbaşı Group to commercialize the marine-derived anticancer drug Aplidin®...


25 May, 2017, 09:00 ET Global Veterinary Vaccines Market 2017-2021: Market is Expected to Benefit from the Growing Concern Over Food Safety - Research and Markets

Research and Markets has announced the addition of the "Global Veterinary Vaccines Market 2017-2021" report to their offering. The analysts...


25 May, 2017, 09:00 ET Hepatera: Eligibility to PRIME Scheme Granted to Myrcludex B by the European Medicines Agency

MYR GmbH and its development partner Hepatera LLC today announced that the European Medicines Agency (EMA) granted "PRIME eligibility" for...


25 May, 2017, 09:00 ET Hovione Announces Start of Phase 1 Clinical Trial of HY02, a Proprietary Minocycline Sterile Ointment to Treat a Subset of Anterior Ocular Inflammation

Hovione today announced the launch of its first clinical trial. Hovione will soon initiate recruitment for its Phase 1 clinical trial of HY02, a...


25 May, 2017, 08:30 ET Rosa & Co. Announces the Appointment of Matt Marano as Senior Vice President of Business Development

Rosa & Co., LLC is proud to welcome Matt Marano as the company's Senior Vice President of Business Development. Mr. Marano will be responsible...


25 May, 2017, 08:00 ET EMD Serono to Present Data Highlighting Investigational Cladribine Tablets at CMSC 2017

EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany, in the US and Canada, today announced 14 presentations, including...


25 May, 2017, 08:00 ET Positive Results in Research Delaying Onset of Motor Neurone Disease Announced by Sheffield University and British Artificial Intelligence Firm BenevolentAI

The Sheffield Institute for Translational Neuroscience (SITraN), part of the University of Sheffield and one of the world's leading centres for...


25 May, 2017, 07:06 ET Compugen Announces Appointment of Dr. Michal Preminger to Board of Directors

Compugen Ltd. (NASDAQ: CGEN), a therapeutic discovery company, today announced that Michal Preminger, PhD, MBA, Executive Director at Harvard...


25 May, 2017, 07:00 ET Touch Medical Media Announces Axel Merseburger as Editor-in-chief of European Oncology & Haematology

Touch Medical Media has named Prof. Axel Merseburger as the new Editor-in-Chief of their journal European Oncology & Haematology, a peer...


25 May, 2017, 07:00 ET Shire to Participate at the Jefferies Healthcare Conference

Shire plc (LSE: SHP, NASDAQ: SHPG) announces that Flemming Ornskov, MD, Chief Executive Officer, will participate at the Jefferies Healthcare...


25 May, 2017, 07:00 ET BioLineRx Reports First Quarter 2017 Financial Results

BioLineRx Ltd. (NASDAQ/TASE: BLRX), a clinical-stage biopharmaceutical company focused on oncology and immunology, today reports its financial...


25 May, 2017, 07:00 ET Akcea Announces Publication in The New England Journal of Medicine of Data with AKCEA-ANGPTL3-L Rx Showing Favorable Cardiometabolic Effects

Akcea Therapeutics, a wholly owned subsidiary of Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), today announced the publication in The New England...


25 May, 2017, 06:15 ET Biotech Stocks Under Scanner -- Juno Therapeutics, Nektar Therapeutics, Threshold Pharma, and Bellerophon Therapeutics

The Biotech space consists of companies engaged in the research and development of new drugs, medical devices, and procedures. The industry...


25 May, 2017, 06:00 ET CureMatch Announces Pricing for its Cutting-Edge Combination Therapy Report for Cancer Treatment

CureMatch™ today announced the pricing for its Personalized Combination Therapy™ report. The report guides oncologists in the selection of cancer...


25 May, 2017, 03:00 ET GW Pharmaceuticals und US-Tochtergesellschaft Greenwich Biosciences kündigen die Veröffentlichung einer bahnbrechenden Studie zu Epidiolex® (Cannabidiol) im New England Journal of Medicine an

- Pharmazeutische Cannabidiol-Formulierung reduziert signifikant die Häufigkeit von Krampfanfällen bei Kindern, die schlecht auf Behandlung mit...


25 May, 2017, 03:00 ET GW Pharmaceuticals y Greenwich Biosciences publican un estudio revolucionario de Epidiolex® (cannabidiol)

- GW Pharmaceuticals y su filial estadounidense Greenwich Biosciences anuncian la publicación de un estudio revolucionario de Epidiolex®...


25 May, 2017, 03:00 ET GW Pharmaceuticals et sa filiale américaine Greenwich Biosciences, annoncent la publication d'une étude révolutionnaire sur Epidiolex® (cannabidiol), dans The New England Journal of Medicine

- L'élaboration pharmaceutique du cannabidiol a considérablement réduit la fréquence des crises convulsives chez les enfants utilisant de...


25 May, 2017, 03:00 ET GW Pharmaceuticals e la sua controllata statunitense Greenwich Biosciences annunciano la pubblicazione di uno studio rivoluzionario su Epidiolex® (cannabidiolo) nel New England Journal of Medicine

- La formulazione farmaceutica del cannabidiolo ha ridotto notevolmente la frequenza degli attacchi convulsivi nei bambini in cura con molteplici...


24 May, 2017, 23:53 ET OncoQuest presenta los resultados clínicos internos de fase II de Oregovomab para el tratamiento de primera línea del cáncer de ovario en el congreso anual de la American Society of Clinical Oncology (ASCO)

OncoQuest Inc. ('OncoQuest'), una compañía biofarmacéutica de propiedad privada centrada en el desarrollo y comercialización de productos...


24 May, 2017, 17:30 ET Medicure Reports Financial Results for Quarter Ended March 31, 2017

WINNIPEG, May 24, 2017 /PRNewswire/ - Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH, OTC:MCUJF), a specialty pharmaceutical company, today...


24 May, 2017, 17:21 ET Anything Technologies Media Inc's Subsidiary International Sustainability Group Inc, (ISGP), Acquires, iMD Meds, Hydroponics, CBD, and Hemp Energy Protein Bar Division for 125 Million Common Shares

PLACERVILLE, CA, May 24, 2017 /PRNewswire/ - Anything Technologies Media Inc's. (OTC: EXMT) Board of Directors announced today that its subsidiary...


24 May, 2017, 16:30 ET Allergan Announces Pricing of Tender Offers by Certain Subsidiaries

Allergan plc (NYSE: AGN) today announced the consideration payable in connection with the previously announced tender offers commenced by its...